Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · IEX Real-Time Price · USD
1.840
-0.100 (-5.15%)
At close: Jul 19, 2024, 4:00 PM
1.790
-0.050 (-2.72%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $73.71 million as of July 22, 2024. Its market cap has increased by 58.17% in one year.
Market Cap
73.71M
Enterprise Value
39.70M
1-Year Change
58.17%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $73.71M, a decrease of -71.26%. That is a compound annual growth rate of -36.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 73.70M | 30.91% |
| Dec 29, 2023 | 56.30M | 11.93% |
| Dec 30, 2022 | 50.30M | -63.89% |
| Dec 31, 2021 | 139.30M | -45.68% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eagle Pharmaceuticals | 76.23M |
| Genelux | 75.92M |
| Spero Therapeutics | 75.58M |
| enVVeno Medical | 75.45M |
| Kronos Bio | 75.12M |
| HeartBeam | 73.19M |
| Ovid Therapeutics | 72.36M |
| Theratechnologies | 71.73M |